Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Announces Robert Lisicki as CEO and Director
Zura Bio Limited (NASDAQ: ZURA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $16.00 price target on the stock, down previously from $17.00.
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer [Yahoo! Finance]
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer